This document describes research into developing a new formulation map for high-shear wet granulation processes using on-line torque measurements. The researchers conducted experiments varying formulation parameters like binder type and amount, as well as diluent particle size, to determine the minimum liquid volume needed for granule growth. They found that granulation onset, identified by an abrupt increase in torque, requires the liquid added to exceed a minimum threshold volume. This minimum liquid volume depends on factors like the dry binder type, amount, and diluent properties. They also showed this formulation map could be constructed using independent measurements of binder glass transition temperatures under different humidity conditions.
The document evaluates different binders for use in moist aqueous granulation (MAG) formulations of high-dose metformin HCL. Four binders - vinylpyrrolidone-vinyl acetate copolymer, polyvidone, hydroxypropyl cellulose, and hydroxypropyl methylcellulose - were tested. Granules made with hydroxypropyl methylcellulose were not sufficiently granulated with a low water volume. Granules containing hydroxypropyl cellulose had a tendency to form bowls during tableting, while those with polyvidone tended to stick. Vinylpyrrolidone-vinyl acetate copolymer granules maintained proper moisture balance and flow the best. The type of binder used
Extrusion is a process used to create new materials with desirable properties. Recent advances in hot melt extrusion (HME) technology include using lower processing temperatures, pressurized carbon dioxide as a reversible plasticizer, and coupling HME with other technologies like 3D printing. Case studies demonstrated how HME can produce formulations with content uniformity at low doses and how pressurized carbon dioxide can affect the properties of ketoprofen formulations. Overall, HME is a continuous process that is being advanced to overcome weaknesses and expand its applications in pharmaceutical manufacturing.
Formulation and evaluation of lovastatin porous tabletsSriramNagarajan17
This document summarizes the formulation and evaluation of lovastatin porous tablets. Lovastatin tablets were formulated using microcrystalline cellulose, camphor, menthol, crospovidone, crosscarmellose sodium, and magnesium stearate. The tablets were evaluated for parameters like thickness, hardness, friability, weight variation, drug content, and disintegration time both before and after drying. Formulation F6 containing 10% menthol showed the fastest disintegration time of less than 1 minute after drying, indicating menthol is the most effective subliming agent for producing porosity in the tablets. All evaluation parameters were within specified limits. Thus, porous lovastatin tablets with rapid drug release were successfully developed using
The document describes the development of calcium alginate beads for oral delivery of the antibiotic ceftriaxone sodium. Twelve formulations of calcium alginate beads were developed using an ionotropic gelation method. The optimized formulation achieved high drug entrapment efficiency (>75%) and provided sustained drug release over 10-18 hours. Scanning electron microscopy indicated the coated optimized beads had a smooth surface and fewer pores, slowing the drug release rate compared to uncoated beads. The calcium alginate beads have potential as a drug delivery system for oral administration of ceftriaxone sodium.
The document presents an abstract for developing orally disintegrating tablets using microwave technology. Microwave technology applies the principle of heating polar molecules through vibration to generate pores in tablets for rapid disintegration, without compromising hardness. A bitter drug was complexed with beta-cyclodextrin to enhance solubility and mask bitterness. Tablets were prepared conventionally and exposed to humidity and microwaves to form pores. Crosspovidone was identified as the optimal superdisintegrant. A 23 factorial design was used to optimize the formulation's critical quality attributes of disintegration time and hardness based on superdisintegrant concentration and humidity/microwave exposure times. The optimized formulation showed a disintegration time of 23 seconds and hardness of
formulation and evaluation of microbeadsgurleen kaur
Microencapsulation has been employed to sustain the drug release, reduce or eliminate drug related adverse effects, dose intake and improve the bioavailability inspite drug undergo extensive first pass metabolism ultimately improve the compliance in pharmacotherapy of inflammation and pain.
Microencapsulation by ionotropic gelation technique is one of the widely used method for preparation of calcium alginate beads which has ability to form gels reaction with calcium salts .
Microencapsulation has been employed to sustain the drug release, reduce or eliminate drug related adverse effects, dose intake and improve the bioavailability inspite drug undergo extensive first pass metabolism ultimately improve the compliance in pharmacotherapy of inflammation and pain.
Microencapsulation by ionotropic gelation technique is one of the widely used method for preparation of calcium alginate beads which has ability to form gels reaction with calcium salts .
The document evaluates different binders for use in moist aqueous granulation (MAG) formulations of high-dose metformin HCL. Four binders - vinylpyrrolidone-vinyl acetate copolymer, polyvidone, hydroxypropyl cellulose, and hydroxypropyl methylcellulose - were tested. Granules made with hydroxypropyl methylcellulose were not sufficiently granulated with a low water volume. Granules containing hydroxypropyl cellulose had a tendency to form bowls during tableting, while those with polyvidone tended to stick. Vinylpyrrolidone-vinyl acetate copolymer granules maintained proper moisture balance and flow the best. The type of binder used
Extrusion is a process used to create new materials with desirable properties. Recent advances in hot melt extrusion (HME) technology include using lower processing temperatures, pressurized carbon dioxide as a reversible plasticizer, and coupling HME with other technologies like 3D printing. Case studies demonstrated how HME can produce formulations with content uniformity at low doses and how pressurized carbon dioxide can affect the properties of ketoprofen formulations. Overall, HME is a continuous process that is being advanced to overcome weaknesses and expand its applications in pharmaceutical manufacturing.
Formulation and evaluation of lovastatin porous tabletsSriramNagarajan17
This document summarizes the formulation and evaluation of lovastatin porous tablets. Lovastatin tablets were formulated using microcrystalline cellulose, camphor, menthol, crospovidone, crosscarmellose sodium, and magnesium stearate. The tablets were evaluated for parameters like thickness, hardness, friability, weight variation, drug content, and disintegration time both before and after drying. Formulation F6 containing 10% menthol showed the fastest disintegration time of less than 1 minute after drying, indicating menthol is the most effective subliming agent for producing porosity in the tablets. All evaluation parameters were within specified limits. Thus, porous lovastatin tablets with rapid drug release were successfully developed using
The document describes the development of calcium alginate beads for oral delivery of the antibiotic ceftriaxone sodium. Twelve formulations of calcium alginate beads were developed using an ionotropic gelation method. The optimized formulation achieved high drug entrapment efficiency (>75%) and provided sustained drug release over 10-18 hours. Scanning electron microscopy indicated the coated optimized beads had a smooth surface and fewer pores, slowing the drug release rate compared to uncoated beads. The calcium alginate beads have potential as a drug delivery system for oral administration of ceftriaxone sodium.
The document presents an abstract for developing orally disintegrating tablets using microwave technology. Microwave technology applies the principle of heating polar molecules through vibration to generate pores in tablets for rapid disintegration, without compromising hardness. A bitter drug was complexed with beta-cyclodextrin to enhance solubility and mask bitterness. Tablets were prepared conventionally and exposed to humidity and microwaves to form pores. Crosspovidone was identified as the optimal superdisintegrant. A 23 factorial design was used to optimize the formulation's critical quality attributes of disintegration time and hardness based on superdisintegrant concentration and humidity/microwave exposure times. The optimized formulation showed a disintegration time of 23 seconds and hardness of
formulation and evaluation of microbeadsgurleen kaur
Microencapsulation has been employed to sustain the drug release, reduce or eliminate drug related adverse effects, dose intake and improve the bioavailability inspite drug undergo extensive first pass metabolism ultimately improve the compliance in pharmacotherapy of inflammation and pain.
Microencapsulation by ionotropic gelation technique is one of the widely used method for preparation of calcium alginate beads which has ability to form gels reaction with calcium salts .
Microencapsulation has been employed to sustain the drug release, reduce or eliminate drug related adverse effects, dose intake and improve the bioavailability inspite drug undergo extensive first pass metabolism ultimately improve the compliance in pharmacotherapy of inflammation and pain.
Microencapsulation by ionotropic gelation technique is one of the widely used method for preparation of calcium alginate beads which has ability to form gels reaction with calcium salts .
Fabrication and evaluation of a stable flurbiprofen hydrogelpharmaindexing
This study aimed to fabricate and evaluate a stable 6% flurbiprofen hydrogel for topical delivery. Flurbiprofen hydrogel was prepared using carbopol 940 as the thickening agent. Stability studies were conducted over 28 days at different temperatures (2-40°C, 25°C, 40°C) by assessing parameters like liquefaction, color, phase separation, centrifugation and pH. The hydrogel showed no changes in these parameters, and pH values remained stable. Drug content of the hydrogel was 76.3% flurbiprofen. In vitro drug release studies found 79.46% of drug was released after 8 hours, indicating the formulation was stable for topical use.
This document discusses the formulation and evaluation of bilayer tablets containing domperidone maleate. Bilayer tablets provide dual drug release and separation of incompatible substances. Domperidone is an antiemetic and used to treat nausea. Various pre-compression studies were conducted on formulations to optimize flow and compressibility. Tablets were developed using wet granulation and contained different polymers for immediate and sustained release layers. Post-compression testing included weight variation, hardness, friability, disintegration and dissolution studies. The project timeline included formulation, evaluation, stability studies and report preparation over 4 months.
Effect of diluent types and soluble diluents particle size on the dissolution...Valentyn Mohylyuk
Effect of different diluents types on the dissolution profile of trimetazidine dihydrochloride and caffeine from Kollidon SR matrix tablets was investigated using microcrystalline cellulose (Avicel PH-101), calcium hydrogen phosphate dihydrate (Emcompress) and sorbitol (Neosorb P100T). The decreasing of mentioned diluents possibility to slow down of model substances dissolution kinetics (at pH 6.8) had follow sequence: Avicel PH-101 > Emcompress > Neosorb P100T.Effect of soluble diluents particle size on dissolution profile of trimetazidine dihydrochloride and caffeine from Kollidon SR matrix tablets was investigated using sorbitol (Neosorb P100T, Neosorb P60 W and Neosorb P30/60) and lactose monohydrate (Sorbolac 400, Granulac 200 and Capsulac 60). The particle size increasing of lactose monohydrate from 11 to 251 μm and sorbitol from 110 to 513 μm decreased dissolution kinetics of model substances from Kollidon SR matrix tablets. Keywords : matrix tablets, Kollidon SR, caffeine, trimetazidine, diluent, particle size.
Development and characterization of porous starch curcumin solid dispertion...NikitaGidde
1) The document discusses the preparation and evaluation of solid dispersions of curcumin and porous starch to enhance the solubility of curcumin.
2) Curcumin is poorly water soluble, so various ratios of curcumin-porous starch solid dispersions were prepared by ball milling.
3) The solid dispersions showed improved flow properties and a 1-2 fold increase in curcumin's solubility compared to curcumin alone. They also exhibited significantly faster drug dissolution.
This document discusses using gelatin beads as a sustained release drug delivery system. Gelatin beads can provide sustained release of drugs over time by taking advantage of their large surface area and diffusion properties. The document describes preparing and evaluating propranolol HCl loaded gelatin beads using natural polymers gelatin and fish gelatin crosslinked with glutaraldehyde. The beads were evaluated for loading efficiency, yield, in vitro drug release, and stability over 3 months of accelerated conditions. Overall, the document proposes that gelatin beads can serve as a biocompatible drug delivery system for sustained drug release.
This document describes the development and evaluation of bilayer tablets containing capecitabine and ondansetron. The bilayer tablet uses Dual Release Drug Absorption System (DUREDAS) technology, providing sustained release of capecitabine in one layer and immediate release of ondansetron in another layer. Various excipients were evaluated to optimize the drug release profiles from each layer. Pre-formulation studies and tablet evaluations were conducted to develop a cost-effective bilayer tablet formulation for once-daily treatment of nausea and vomiting.
Foam fractionation as a means to recover and fractionate bioactiveseSAT Journals
Abstract In this research, the optimum conditions for the separation of polyphenols from apple juice (AJ) and the separation of BSA from a BSA/water solution were found by looking at the enrichment ratio (ER) and recovery. A mixture of the AJ and BSA was also studied to see how the different conditions affect separation of either compound. For AJ only, maximum ER was achieved at a feed concentration of 0.00184mg/mL of polyphenols (10.9˚Brix), air flowrate of 10mL/min, pH of 6.03 and temperature of 4.1˚C. For the BSA only solution, maximum ER was achieved at a feed concentration of 2.5g/L, air flowrate of 7mL/min, pH of 5-6 and temperature either above or below 20˚C. For the mixture, maximum polyphenol ER was at a feed polyphenol concentration of 0.0018mg/mL, feed BSA concentration of 5g/L and a pH of 3.7. Whereas maximum BSA ER was achieved when the feed polyphenol concentration was again 0.00184mg/mL, but a minimum was seen at 5g/L BSA feed concentration and pH of 3.7. These results show that there are interactions between the polyphenol and proteins that affects the separation of compounds. The bubble size distribution and gas hold-up of the AJ and BSA solutions were then compared and the BSA solution had larger bubbles present and a greater gas hold-up, which is attributed to the greater surface activity of BSA protein. Finally basic modelling – linear regression, was performed to link the ER to the different conditions tested. The models were judged by comparing R2 values, the F-statistic and the p-value and all showed weak relationships between the ER and the independent variables. Further data is required to improve the model as from previous literatures these variables have been seen to contribute to adsorption, which in turn affects the ER.
Development and evaluation of xyloglucan matrix release tabs contaning glipizidesukesh
The document describes a research project that developed and evaluated matrix release tablets containing the drug glipizide using xyloglucan as a polymer. Xyloglucan was extracted from tamarind kernels and used to prepare different tablet formulations. Tablets were evaluated for dissolution, drug release, and other parameters. The best formulation was F1, which released 99% of the drug in a prolonged manner and could be used for extended release of glipizide.
Development and formulation of metoprolol succinate extended release tablets ...srirampharma
The document summarizes the preformulation characterization of metoprolol succinate extended release tablets. Key tests included determining the drug's percentage compressibility, stability in water and buffers, solubility, and compatibility with excipients. The percentage compressibility of 13.94% supported use of direct compression. Stability studies showed no degradation in water, buffer, or HCl. Compatibility by physical mixing and IR spectroscopy found no interactions between the drug and excipients. Solubility in water was determined to be 95896μg/ml. The results supported formulation development of metoprolol succinate ER tablets by direct compression.
The document discusses preformulation and summarizes some of its key aspects. Preformulation involves determining the physicochemical properties of new drug substances to aid in developing effective dosage forms. It covers topics like organoleptic properties, purity, particle size and shape, solubilization using surfactants, and the effect of temperature, pH and co-solvents on solubility. It also mentions the importance of preformulation stability studies and considering drug characteristics for different dosage forms. The goals of preformulation are establishing parameters, kinetic profiles, physical characteristics and compatibility with excipients.
Formulation and Evaluation of Pantoprazole Sodium Enteric Coated TabletsSriramNagarajan18
The document summarizes the formulation and evaluation of pantoprazole sodium enteric coated tablets. Pantoprazole is an acid-labile drug that requires enteric coating to protect it from degradation in the stomach. Various enteric coated tablet formulations were prepared using different concentrations of superdisintegrants and enteric coating polymers. Tablets were evaluated for hardness, thickness, weight variation, friability, drug content and in vitro drug release. Formulation EC8, coated with 6% Eudragit RS100, showed the best results with a thickness of 2.2mm, hardness of 3.52kg/cm2, drug release of 100.16% within 2 hours and 45 minutes, and acid resistance
Cubosomal nanoparticles as an ocular delivery system of fluconazoleSidharth Mehta
The optimized cubosomal dispersion exhibited spherical nanosized particles and reasonable EE% along with higher
FCZ corneal permeation (twofold) as compared to that of FCZ solution.
Moreover, the in vivo study proved the efficacy and safety FCZ-loaded
cubosomal dispersion in treatment of induced keratomycosis
in rats compared to aqueous FCZ solution after topical ocular
application.
Based on the previous results, the use of
cubosomal dispersion as an ocular drug delivery system is
expected to improve antifungal activity of FCZ in treatment
of fungal keratitis.
Formulation and evaluation of gastroretentive ciprofloxacin hcl effervescent ...Sagar Savale
Ciprofloxacin HCL is an effervescent Tablet is made by Wet Granulation Method. Ciprofloxacin is a broad
spectrum Fluroquinolon antibiotics. Is mainly used for various Bacterial Infections. In this tablet bitter taste
was masked by saccharine as sweeting agent furthermore the effervescent effect of citric acid, tartaric acid
and sodium bicarbonate lead to Effervescent activity by realising the CO2 Molecule. Tablets are rapidly
dissolved and rapidly absorbed and give maximum activity. The Prepared Effervescent Tablet is Evaluated
In terms of bulk density, tapped density, angle of repose, Carr’s Index and, hardness test, weight variation
test, friability test and in vitro study. The result associated in Optimized batch is good to Satisfactory and
having a good free flowing property. The hardness, weight variation, and friability these values are within
the pharmacopeia limit. The in vitro Dissolution studies show Maximum percentage of release of drug
(99.26) with in end of 5 min.
Formulation and evaluation of metformin and rosuvastatin bilayered tabletsSriramNagarajan17
This document describes the formulation and evaluation of bilayer tablets containing metformin hydrochloride as the sustained release layer and rosuvastatin as the immediate release layer. Various formulations of each layer were prepared using different polymers, excipients, and manufacturing methods. The metformin layer was prepared by wet granulation while the rosuvastatin layer used direct compression. Physicochemical properties of granules and tablets were evaluated. Standard calibration curves were developed for both drugs to enable drug content analysis. The optimized formulations demonstrated desired drug release profiles with the metformin layer providing sustained release over 12 hours and the rosuvastatin layer releasing completely within 1 hour.
Formulation and evaluation ofmetformin HCl micro beads by ionotropic gelation...Sagar Savale
The Metformin HCL Micro Beads is formulated by the Ionotropic Gelation Method. The CMC is a Swellable
polymer is responsible for the Sustained release action or activity. A combination of CMC (Carboxy Methyl
Cellulose) and Sodium Alginate shows better sustained release activity. The PreparedSustained released Micro
Beadsis Evaluated In terms of bulk density, tapped density, angle of repose, Carr’s Index, Swelling Index, Drug
Content, % Encapsulation Efficiency and vitro study. The result associated in Optimized batch is good to
Satisfactory and having a good free flowing property. The Drug Content and % Encapsulation Efficiency values are
within the pharmacopeia limit. The in vitro Dissolution studies shows Maximum percentage of release of drug
(71.15) with in end of 4 Hours.
This document provides an overview of amorphous solid dispersions. It discusses glass transition temperature and how polymers can inhibit drug crystallization as a carrier matrix. Preparation methods like hot melt extrusion and solvent evaporation are described. Characterization techniques involve thermal analysis, spectroscopy and diffraction to analyze phase composition and molecular arrangement. In vitro tests examine the "spring and parachute" effect where drug dissolution increases initially before precipitation occurs without proper inhibition. Amorphous solid dispersions provide a formulation strategy for improving solubility of poorly water soluble drug candidates.
poorly soluble drugs and solid dispersionsrcdreddi
The document discusses amorphous solid dispersions and their advantages over crystalline forms. It examines the preparation and characterization of solid dispersions using hydrocortisone as a model drug and PVP as a carrier. The influence of drug to carrier ratio, solvent composition, and processing method are investigated. Spray drying and freeze drying were used to prepare dispersions from ethanol or ethanol/water solutions. Drug to carrier ratio, solvent composition, and processing method all impacted properties like glass transition temperature, moisture content, and drug dissolution rate from the solid dispersions. Further characterization and stability testing of the amorphous dispersions are recommended.
Solid dispersion is an effective way of improving the dissolution rate of poorly water soluble drugs and hence its bioavailability. The water soluble carriers used in preparation of solid dispersion enhance the dissolution rate of the poorly water soluble drug. This work reflects the improvement of Dissolution Characteristics as well as Bioavailability of poorly aqueous soluble drug Hydrochlorothiazide. It belongs to BCS class 2 i.e. it has poor water solubility but good permeability.
Nanoemulsion Characterisation Techniques and Formulation Methodsijtsrd
Nanoemulsions are thermodynamically stable colloidal dispersion systems made up of two immiscible liquids combined with emulsifying agents surfactants and co surfactants to produce a single phase. Nanoemulsions have been studied extensively as drug delivery devices. This review attempts to bring together information on the many nanoemulsion formulation and characterization techniques that have been developed. The persuasion approach and the Brute force method are two methods for creating nanoemulsions. Entrapment efficiency, particle size, polydispersity index, zeta potential, and characterization using differential scanning calorimetry, Fourier transform infrared spectroscopy, and transmission electron microscopy are just a few of the techniques used to characterise nanoemulsions. In vitro drug release, in vitro permeation, stability and thermodynamic stability, shelf life, dispersibility, viscosity, surface tension, friccohesity, refractive index, transmittance, pH, and osmolarity are all used to assess nanoemulsions. Rohit Ghogare | Prof. Santosh Waghmare | Dr. Hemant Kamble "Nanoemulsion- Characterisation Techniques and Formulation Methods" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-3 , April 2022, URL: https://www.ijtsrd.com/papers/ijtsrd49586.pdf Paper URL: https://www.ijtsrd.com/pharmacy/other/49586/nanoemulsion-characterisation-techniques-and-formulation-methods/rohit-ghogare
This document discusses gastro-retentive drug delivery systems (GRDDS). It describes the different approaches for GRDDS, including high density systems, floating systems, swelling systems, and bioadhesive systems. Floating systems are further divided into hydrodynamically balanced systems, gas-generating systems, and raft-forming systems. The document also covers evaluation methods for GRDDS such as dissolution testing and imaging with barium sulfate and X-rays. The goal of these systems is to prolong the gastric retention of drugs to increase their bioavailability.
Fabrication and evaluation of a stable flurbiprofen hydrogelpharmaindexing
This study aimed to fabricate and evaluate a stable 6% flurbiprofen hydrogel for topical delivery. Flurbiprofen hydrogel was prepared using carbopol 940 as the thickening agent. Stability studies were conducted over 28 days at different temperatures (2-40°C, 25°C, 40°C) by assessing parameters like liquefaction, color, phase separation, centrifugation and pH. The hydrogel showed no changes in these parameters, and pH values remained stable. Drug content of the hydrogel was 76.3% flurbiprofen. In vitro drug release studies found 79.46% of drug was released after 8 hours, indicating the formulation was stable for topical use.
This document discusses the formulation and evaluation of bilayer tablets containing domperidone maleate. Bilayer tablets provide dual drug release and separation of incompatible substances. Domperidone is an antiemetic and used to treat nausea. Various pre-compression studies were conducted on formulations to optimize flow and compressibility. Tablets were developed using wet granulation and contained different polymers for immediate and sustained release layers. Post-compression testing included weight variation, hardness, friability, disintegration and dissolution studies. The project timeline included formulation, evaluation, stability studies and report preparation over 4 months.
Effect of diluent types and soluble diluents particle size on the dissolution...Valentyn Mohylyuk
Effect of different diluents types on the dissolution profile of trimetazidine dihydrochloride and caffeine from Kollidon SR matrix tablets was investigated using microcrystalline cellulose (Avicel PH-101), calcium hydrogen phosphate dihydrate (Emcompress) and sorbitol (Neosorb P100T). The decreasing of mentioned diluents possibility to slow down of model substances dissolution kinetics (at pH 6.8) had follow sequence: Avicel PH-101 > Emcompress > Neosorb P100T.Effect of soluble diluents particle size on dissolution profile of trimetazidine dihydrochloride and caffeine from Kollidon SR matrix tablets was investigated using sorbitol (Neosorb P100T, Neosorb P60 W and Neosorb P30/60) and lactose monohydrate (Sorbolac 400, Granulac 200 and Capsulac 60). The particle size increasing of lactose monohydrate from 11 to 251 μm and sorbitol from 110 to 513 μm decreased dissolution kinetics of model substances from Kollidon SR matrix tablets. Keywords : matrix tablets, Kollidon SR, caffeine, trimetazidine, diluent, particle size.
Development and characterization of porous starch curcumin solid dispertion...NikitaGidde
1) The document discusses the preparation and evaluation of solid dispersions of curcumin and porous starch to enhance the solubility of curcumin.
2) Curcumin is poorly water soluble, so various ratios of curcumin-porous starch solid dispersions were prepared by ball milling.
3) The solid dispersions showed improved flow properties and a 1-2 fold increase in curcumin's solubility compared to curcumin alone. They also exhibited significantly faster drug dissolution.
This document discusses using gelatin beads as a sustained release drug delivery system. Gelatin beads can provide sustained release of drugs over time by taking advantage of their large surface area and diffusion properties. The document describes preparing and evaluating propranolol HCl loaded gelatin beads using natural polymers gelatin and fish gelatin crosslinked with glutaraldehyde. The beads were evaluated for loading efficiency, yield, in vitro drug release, and stability over 3 months of accelerated conditions. Overall, the document proposes that gelatin beads can serve as a biocompatible drug delivery system for sustained drug release.
This document describes the development and evaluation of bilayer tablets containing capecitabine and ondansetron. The bilayer tablet uses Dual Release Drug Absorption System (DUREDAS) technology, providing sustained release of capecitabine in one layer and immediate release of ondansetron in another layer. Various excipients were evaluated to optimize the drug release profiles from each layer. Pre-formulation studies and tablet evaluations were conducted to develop a cost-effective bilayer tablet formulation for once-daily treatment of nausea and vomiting.
Foam fractionation as a means to recover and fractionate bioactiveseSAT Journals
Abstract In this research, the optimum conditions for the separation of polyphenols from apple juice (AJ) and the separation of BSA from a BSA/water solution were found by looking at the enrichment ratio (ER) and recovery. A mixture of the AJ and BSA was also studied to see how the different conditions affect separation of either compound. For AJ only, maximum ER was achieved at a feed concentration of 0.00184mg/mL of polyphenols (10.9˚Brix), air flowrate of 10mL/min, pH of 6.03 and temperature of 4.1˚C. For the BSA only solution, maximum ER was achieved at a feed concentration of 2.5g/L, air flowrate of 7mL/min, pH of 5-6 and temperature either above or below 20˚C. For the mixture, maximum polyphenol ER was at a feed polyphenol concentration of 0.0018mg/mL, feed BSA concentration of 5g/L and a pH of 3.7. Whereas maximum BSA ER was achieved when the feed polyphenol concentration was again 0.00184mg/mL, but a minimum was seen at 5g/L BSA feed concentration and pH of 3.7. These results show that there are interactions between the polyphenol and proteins that affects the separation of compounds. The bubble size distribution and gas hold-up of the AJ and BSA solutions were then compared and the BSA solution had larger bubbles present and a greater gas hold-up, which is attributed to the greater surface activity of BSA protein. Finally basic modelling – linear regression, was performed to link the ER to the different conditions tested. The models were judged by comparing R2 values, the F-statistic and the p-value and all showed weak relationships between the ER and the independent variables. Further data is required to improve the model as from previous literatures these variables have been seen to contribute to adsorption, which in turn affects the ER.
Development and evaluation of xyloglucan matrix release tabs contaning glipizidesukesh
The document describes a research project that developed and evaluated matrix release tablets containing the drug glipizide using xyloglucan as a polymer. Xyloglucan was extracted from tamarind kernels and used to prepare different tablet formulations. Tablets were evaluated for dissolution, drug release, and other parameters. The best formulation was F1, which released 99% of the drug in a prolonged manner and could be used for extended release of glipizide.
Development and formulation of metoprolol succinate extended release tablets ...srirampharma
The document summarizes the preformulation characterization of metoprolol succinate extended release tablets. Key tests included determining the drug's percentage compressibility, stability in water and buffers, solubility, and compatibility with excipients. The percentage compressibility of 13.94% supported use of direct compression. Stability studies showed no degradation in water, buffer, or HCl. Compatibility by physical mixing and IR spectroscopy found no interactions between the drug and excipients. Solubility in water was determined to be 95896μg/ml. The results supported formulation development of metoprolol succinate ER tablets by direct compression.
The document discusses preformulation and summarizes some of its key aspects. Preformulation involves determining the physicochemical properties of new drug substances to aid in developing effective dosage forms. It covers topics like organoleptic properties, purity, particle size and shape, solubilization using surfactants, and the effect of temperature, pH and co-solvents on solubility. It also mentions the importance of preformulation stability studies and considering drug characteristics for different dosage forms. The goals of preformulation are establishing parameters, kinetic profiles, physical characteristics and compatibility with excipients.
Formulation and Evaluation of Pantoprazole Sodium Enteric Coated TabletsSriramNagarajan18
The document summarizes the formulation and evaluation of pantoprazole sodium enteric coated tablets. Pantoprazole is an acid-labile drug that requires enteric coating to protect it from degradation in the stomach. Various enteric coated tablet formulations were prepared using different concentrations of superdisintegrants and enteric coating polymers. Tablets were evaluated for hardness, thickness, weight variation, friability, drug content and in vitro drug release. Formulation EC8, coated with 6% Eudragit RS100, showed the best results with a thickness of 2.2mm, hardness of 3.52kg/cm2, drug release of 100.16% within 2 hours and 45 minutes, and acid resistance
Cubosomal nanoparticles as an ocular delivery system of fluconazoleSidharth Mehta
The optimized cubosomal dispersion exhibited spherical nanosized particles and reasonable EE% along with higher
FCZ corneal permeation (twofold) as compared to that of FCZ solution.
Moreover, the in vivo study proved the efficacy and safety FCZ-loaded
cubosomal dispersion in treatment of induced keratomycosis
in rats compared to aqueous FCZ solution after topical ocular
application.
Based on the previous results, the use of
cubosomal dispersion as an ocular drug delivery system is
expected to improve antifungal activity of FCZ in treatment
of fungal keratitis.
Formulation and evaluation of gastroretentive ciprofloxacin hcl effervescent ...Sagar Savale
Ciprofloxacin HCL is an effervescent Tablet is made by Wet Granulation Method. Ciprofloxacin is a broad
spectrum Fluroquinolon antibiotics. Is mainly used for various Bacterial Infections. In this tablet bitter taste
was masked by saccharine as sweeting agent furthermore the effervescent effect of citric acid, tartaric acid
and sodium bicarbonate lead to Effervescent activity by realising the CO2 Molecule. Tablets are rapidly
dissolved and rapidly absorbed and give maximum activity. The Prepared Effervescent Tablet is Evaluated
In terms of bulk density, tapped density, angle of repose, Carr’s Index and, hardness test, weight variation
test, friability test and in vitro study. The result associated in Optimized batch is good to Satisfactory and
having a good free flowing property. The hardness, weight variation, and friability these values are within
the pharmacopeia limit. The in vitro Dissolution studies show Maximum percentage of release of drug
(99.26) with in end of 5 min.
Formulation and evaluation of metformin and rosuvastatin bilayered tabletsSriramNagarajan17
This document describes the formulation and evaluation of bilayer tablets containing metformin hydrochloride as the sustained release layer and rosuvastatin as the immediate release layer. Various formulations of each layer were prepared using different polymers, excipients, and manufacturing methods. The metformin layer was prepared by wet granulation while the rosuvastatin layer used direct compression. Physicochemical properties of granules and tablets were evaluated. Standard calibration curves were developed for both drugs to enable drug content analysis. The optimized formulations demonstrated desired drug release profiles with the metformin layer providing sustained release over 12 hours and the rosuvastatin layer releasing completely within 1 hour.
Formulation and evaluation ofmetformin HCl micro beads by ionotropic gelation...Sagar Savale
The Metformin HCL Micro Beads is formulated by the Ionotropic Gelation Method. The CMC is a Swellable
polymer is responsible for the Sustained release action or activity. A combination of CMC (Carboxy Methyl
Cellulose) and Sodium Alginate shows better sustained release activity. The PreparedSustained released Micro
Beadsis Evaluated In terms of bulk density, tapped density, angle of repose, Carr’s Index, Swelling Index, Drug
Content, % Encapsulation Efficiency and vitro study. The result associated in Optimized batch is good to
Satisfactory and having a good free flowing property. The Drug Content and % Encapsulation Efficiency values are
within the pharmacopeia limit. The in vitro Dissolution studies shows Maximum percentage of release of drug
(71.15) with in end of 4 Hours.
This document provides an overview of amorphous solid dispersions. It discusses glass transition temperature and how polymers can inhibit drug crystallization as a carrier matrix. Preparation methods like hot melt extrusion and solvent evaporation are described. Characterization techniques involve thermal analysis, spectroscopy and diffraction to analyze phase composition and molecular arrangement. In vitro tests examine the "spring and parachute" effect where drug dissolution increases initially before precipitation occurs without proper inhibition. Amorphous solid dispersions provide a formulation strategy for improving solubility of poorly water soluble drug candidates.
poorly soluble drugs and solid dispersionsrcdreddi
The document discusses amorphous solid dispersions and their advantages over crystalline forms. It examines the preparation and characterization of solid dispersions using hydrocortisone as a model drug and PVP as a carrier. The influence of drug to carrier ratio, solvent composition, and processing method are investigated. Spray drying and freeze drying were used to prepare dispersions from ethanol or ethanol/water solutions. Drug to carrier ratio, solvent composition, and processing method all impacted properties like glass transition temperature, moisture content, and drug dissolution rate from the solid dispersions. Further characterization and stability testing of the amorphous dispersions are recommended.
Solid dispersion is an effective way of improving the dissolution rate of poorly water soluble drugs and hence its bioavailability. The water soluble carriers used in preparation of solid dispersion enhance the dissolution rate of the poorly water soluble drug. This work reflects the improvement of Dissolution Characteristics as well as Bioavailability of poorly aqueous soluble drug Hydrochlorothiazide. It belongs to BCS class 2 i.e. it has poor water solubility but good permeability.
Nanoemulsion Characterisation Techniques and Formulation Methodsijtsrd
Nanoemulsions are thermodynamically stable colloidal dispersion systems made up of two immiscible liquids combined with emulsifying agents surfactants and co surfactants to produce a single phase. Nanoemulsions have been studied extensively as drug delivery devices. This review attempts to bring together information on the many nanoemulsion formulation and characterization techniques that have been developed. The persuasion approach and the Brute force method are two methods for creating nanoemulsions. Entrapment efficiency, particle size, polydispersity index, zeta potential, and characterization using differential scanning calorimetry, Fourier transform infrared spectroscopy, and transmission electron microscopy are just a few of the techniques used to characterise nanoemulsions. In vitro drug release, in vitro permeation, stability and thermodynamic stability, shelf life, dispersibility, viscosity, surface tension, friccohesity, refractive index, transmittance, pH, and osmolarity are all used to assess nanoemulsions. Rohit Ghogare | Prof. Santosh Waghmare | Dr. Hemant Kamble "Nanoemulsion- Characterisation Techniques and Formulation Methods" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-3 , April 2022, URL: https://www.ijtsrd.com/papers/ijtsrd49586.pdf Paper URL: https://www.ijtsrd.com/pharmacy/other/49586/nanoemulsion-characterisation-techniques-and-formulation-methods/rohit-ghogare
This document discusses gastro-retentive drug delivery systems (GRDDS). It describes the different approaches for GRDDS, including high density systems, floating systems, swelling systems, and bioadhesive systems. Floating systems are further divided into hydrodynamically balanced systems, gas-generating systems, and raft-forming systems. The document also covers evaluation methods for GRDDS such as dissolution testing and imaging with barium sulfate and X-rays. The goal of these systems is to prolong the gastric retention of drugs to increase their bioavailability.
Establishing Optimal Dehydration Process Parameters for Papaya By EmployingA ...IJERA Editor
This study employs a Firefly Algorithm (FA) to determine the optimal osmotic dehydration parameters for papaya. The functional form of the osmotic dehydration model is established via a standard response surface technique. The format of the resulting optimization model to be solved is a non-linear goal programming problem. While various alternate solution approaches are possible, an FA-driven procedure is employed. For optimization purposes, it has been demonstrated that the FA is more computationally efficient than other such commonly-used metaheuristics as genetic algorithms, simulated annealing, and enhanced particle swarm optimization. Hence, the FA approach is a very computationally efficient procedure. It can be shown that the resulting solution determined for the osmotic process parameters is superior to those from all previous approaches.
Optimizing some conditions for spray drying in synbiotic capsule from Bacillu...inventionjournals
The study is of determination of various conditions for spray drying in producing synbiotic in the form of capsule from Bacillus subtilis natto. The experiments were conducted to examine effects of various factors such as the resistant starch-to-matodextrin ratio before drying, the inlet gas temperature and the inlet flow. The optimization experiments are administered: a ratio of wall materials to the core material is 5% (w/v) in which the ratio of resistant starch and maltodextrin is 1:9, the inlet gas temperatureis 1100C, the inlet flow is 5.60 ml/minute and the spray pressure is 2 bar. In the condition for spray drying as mentioned earlier, the initial step for trial production of synbiotic capsules was conducted with the cell density of B.subtilis natto being 8.55 ± 0.18 log(CFU/g), the activating effect of nattokinase is 518.2 FU/g and the moisture is 9.11%. During 60 days’ preservation of the product, the resulting indexes such as the cell density of B.subtilis natto in the capsule, the activating effect of nattokinase and the moisture are stable.
Optimizing some conditions for spray drying in synbiotic capsule from Bacillu...inventionjournals
The study is of determination of various conditions for spray drying in producing synbiotic in the form of capsule from Bacillus subtilis natto. The experiments were conducted to examine effects of various factors such as the resistant starch-to-matodextrin ratio before drying, the inlet gas temperature and the inlet flow. The optimization experiments are administered: a ratio of wall materials to the core material is 5% (w/v) in which the ratio of resistant starch and maltodextrin is 1:9, the inlet gas temperatureis 1100C, the inlet flow is 5.60 ml/minute and the spray pressure is 2 bar. In the condition for spray drying as mentioned earlier, the initial step for trial production of synbiotic capsules was conducted with the cell density of B.subtilis natto being 8.55 ± 0.18 log(CFU/g), the activating effect of nattokinase is 518.2 FU/g and the moisture is 9.11%. During 60 days’ preservation of the product, the resulting indexes such as the cell density of B.subtilis natto in the capsule, the activating effect of nattokinase and the moisture are stable.
The document discusses various granulation technologies used in pharmaceutical manufacturing. It begins with describing the ideal characteristics of granules and reasons for granulation. Then it discusses several novel granulation technologies including pneumatic dry granulation, freeze granulation, foamed binder technologies, melt granulation, steam granulation, and moisture activated dry granulation. Each technology is briefly described in terms of its process, advantages, and applications. The document emphasizes that pneumatic dry granulation can granulate any pharmaceutical ingredient and has advantages over traditional wet granulation methods.
integrated sophorolipid production and gravity separationBen Dolman
The document describes an integrated method for separating sophorolipid glycolipid biosurfactants from fermentation broth using gravity separation. A novel settling column was developed and demonstrated to continuously remove and recover an enriched sophorolipid phase from the fermenter, while recirculating cells and media back to the bioreactor. This integrated separation approach allowed for an 11% reduction in fermenter volume needed, sophorolipid recoveries up to 86%, and a 34% reduction in mixing power requirements. It also enabled extending the fermentation duration to over 1000 hours and producing over 600g of sophorolipid from an initial 1L batch volume.
To prepare and characterize MCC granules using water and IPA as granulating a...Smruti Chaudhari, Ph.D.
The document describes a study that prepared and characterized microcrystalline cellulose granules using water and isopropyl alcohol as granulating agents. Powder rheology and thermal analysis were used to determine the optimal granule formation and end point of the granulation process. Basic flowability energy, specific energy, permeability, compressibility and aeration ratio were measured using a powder rheometer. Differential scanning calorimetry was also used. The results showed that water granules required more energy than isopropyl alcohol granules. Optimal granules were formed within the range of 45-55% weight for weight of the granulating agent. Thermal analysis supported the determination of the optimal granule formation.
Influence of manufacturing process on physical and flow characteristic and c...Ghazwa Shawash
REFRANCES:
1. www.pubmed.com :
(1) Garg ,A., Gupta ,M., Bhargava ,H.N.. (2007). Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets. European Journal of Pharmaceutics and Biopharmaceutics. 67(3), 725-731.
(2) Närvänen ,T., Lipsanen ,T., Antikainen ,O., Räikkönen ,H.,Yliruusi ,J.. (2008). Controlling granule size by granulation liquid feed pulsing. International Journal of Pharmaceutics. 357(1-2), 132-138.
(3) Ende ,T.a.m., Moses ,K., Carella ,j., Gadkari ,A., Graul ,W., Otano ,L., Timpano ,J. .( 2007). Improving the Content Uniformity of a Low-Dose Tablet Formulation Through Roller Compaction Optimization. Pharmaceutical Development and Technology. 12(4), 391 – 404.
(4) Alkhatib ,H.S., Aiedeh ,K.M., Bustanji ,Y., Hamed ,S., Mohammad ,M.K., Alkhalidi ,B., Najjar ,S.. (2008). Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: Implications for pH-independent release. European Journal of Pharmaceutics and Biopharmaceutics.
(5) Brodka-Pfeiffer ,K., Langguth ,P., Grass ,P., Häusler ,H.. (2003). Influence of mechanical activation on the physical stability of salbutamol sulphate. European Journal of Pharmaceutics and Biopharmaceutics. 56(3), 393-400.
(6) El-Sabawi ,D., Price ,R., Edge ,S., Young ,P.M.. (2006). Novel temperature controlled surface dissolution of excipient particles for carrier based dry powder inhaler formulations. 32(2), 243-51.
(7) Bacher ,C., Olsen ,P.M., Bertelsen ,P., Sonnergaard ,J.M.. (2008). Compressibility and compactibility of granules produced by wet and dry granulation. International Journal of Pharmaceutics. 358(1-2), 69-74.
(8) Bock ,T.K., Kraas ,U.. (2001). Experience with the Diosna mini-granulator and assessment of process scalability. European Journal of Pharmaceutics and Biopharmaceutics. 52(3), 297-303.
(9) Badawy ,S.I., Menning ,M.M., Gorko ,M.A., Gilbert ,D.L. (2000). Effect of process parameters on compressibility of granulation manufactured in a high-shear mixer. International Journal of Pharmaceutics. 198(1), 51-61.
2. advanced pharmacetics: physicochemical principle . cherng-ju Kim.publisher,CRC press.ISBN:0849317290.
3. ansels pharmaceutical dosage form and drug delivery system.loyd V.allen Howard C.Ansel Nicholas G.povich.puplisher:Lippincott William &wilkin.8 th edition.ISBN:0781746124.
4. physical pharmacy , Alfred martin ,ph.d. .
This document discusses coagulation, flocculation, and precipitation techniques used in downstream processing of fermentation broths. Coagulation and flocculation are used for solid-liquid separation, with coagulation rapidly destabilizing particles and flocculation increasing particle size for easier sedimentation. Precipitation is used later in purification and can concentrate or fractionate products by changing conditions like pH or adding salts/solvents to reduce solubility. Controlling these techniques is important for efficient downstream processing and product isolation from fermentation broths.
1. The document discusses validation protocols for pharmaceutical equipment including homogenizers. It describes installation qualification, operational qualification, and performance qualification.
2. Types of homogenizers covered are high pressure homogenizers, microfluidizers, rotor-stator homogenizers, and ultrasonic homogenizers.
3. Validation ensures that equipment is properly installed and will function as specified to consistently produce pharmaceutical products meeting quality standards.
A deeper understanding of the complex expansion mechanism, which leads to the pore structure, is crucial to control expansion product properties. Expansion is caused by flash vaporization of water, due to the high pressure drop at the die exit, and subsequent formation and growth of vapor bubbles (Kokini et al. 1992).
Bananas are harvested according to the desired purpose and this brings the maturity period
into play.
2. Bananas for food are harvested between 17 to 21 weeks because they are fully grown in
this range while those for juice will be harvested from 21 weeks and above as they ripen on
wards (Muranga, 2009).
3. Bananas for extrusion purposes are harvested between 9 to 15 weeks because in this
maturity range, the quantity and quality of starch is highest. (Muranga, 2009).
4. Depending on the conditions the East African Highland Banana is exposed to, like
temperature, humidity, physical damage of the skin among others, the ripening process
commences. This is an irreversible process that involves several chemical and physical
changes on the plant. Of interest to this study is the physical change of the starch levels
along the maturity curve. (Muranga, 2009).
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...shiv
Technology transfer is important for successful progress of drug development from research to commercialization. This presentation discusses technology transfer from research and development to pilot plant and full-scale production of non-sterile semisolids. It covers the importance of pilot plants in scale-up, factors to consider in scaling up semisolids like mixing equipment and homogenization processes. SUPAC guidelines for scale-up and post-approval changes are also summarized. A case study demonstrates issues encountered like congealing during scale-up of a cream formulation containing diethylene glycol monoethyl ether from lab to pilot scale.
PREDICTING OPTIMAL WET GRANULATION PARAMETERS FOR EXTRUSION-SPHERONISATION OF...John Moore
Mixer torque rheometry (MTR) was evaluated for its ability to predict optimal liquid-to-solid ratios (L/S) for producing pharmaceutical pellets via extrusion-spheronization. Various active pharmaceutical ingredients (APIs) were formulated at low and high loadings and tested using MTR to determine the L/S that produced maximum torque during wet mixing (L/SmaxT). Pellets were then extruded-spheronized at L/SmaxT and other L/S ratios and evaluated. L/SmaxT was generally 0.8 for low solubility APIs and decreased to 0.6 for more soluble APIs. Pellets produced at L/S
This document provides an overview of granulation techniques used in pharmaceutical manufacturing. It defines granulation and describes common granulation methods like wet and dry granulation. Wet granulation techniques like high shear and low shear mixing are explained in detail along with novel techniques like moisture activated dry granulation, thermal adhesion granulation, and freeze granulation. Key granulation process parameters and characteristics of granules are also summarized. The document concludes by discussing various granulation technologies and their applications in the pharmaceutical industry.
IRJET - Evaluation of Wheat Husk as Environment Friendly Fluid Loss Addit...IRJET Journal
This document evaluates wheat husk powder (WHP) as an environmentally friendly fluid loss additive to replace carboxymethyl cellulose (CMC) in water-based drilling fluids. Drilling fluids were prepared with varying concentrations of WHP and CMC, and their rheological and filtration properties were tested. The results showed that drilling mud prepared with 3-4% WHP had better filtration properties, with thinner mud cakes and lower fluid loss volumes, compared to mud prepared with CMC. WHP also improved the rheological properties of the mud and provided thermal stability up to 100°C. Therefore, WHP is an effective and environmentally-friendly replacement for CMC as a fluid loss additive in water-
CO–PROCESSED EXCIPIENTS FOR TABLETS.pdfYamini Shah
Purpose of the present review is to provide an in depth knowledge on recent developments in excipients preparation, technology and approaches involved in their formation and development. Excipients play an important role in dosage form development. In conventional formulation of dosage forms, each excipient is used to provide its required function/performance. Presently, excipient manufacturers have focused their attention on producing a multifunctional excipients with improvement in their performance and quality of dosage form. Manipulation in the functionality of excipient is provided by the co-processing of two or more existing excipients.
Formulation and Rheological Evaluation of Ethosome-loaded Carbopol Hydrogel f...ajaykumarpa
Objective: To select a suitable ethosome-loaded Carbopol hydrogel formulation, specifically tailored for transdermal application that exhibits (i) plastic flow with yield stress of approximately 50–80 Pa at low polymer concentration, (ii) relatively frequency independent elastic (G′) and viscous (G″) properties and (iii) thermal stability.
Methods: Carbopol (C71, C934, C941, C971 or C974) hydrogels were prepared by dispersing Carbopol in distilled water followed neutralization by sodium hydroxide. The effects of Carbopol grade, Carbopol concentration, ethosome addition and temperature on flow (yield stress and viscosity) and viscoelastic (G′ and G″) properties of Carbopol hydrogel were evaluated. Based on the aforementioned rheological properties evaluated, suitable ethosome-loaded Carbopol hydrogel was selected. In-vitro permeation studies of diclofenac using rat skin were further conducted on ethosome-loaded Carbopol hydrogel along with diclofenac-loaded ethosomal formulation as control.
Results: Based on preliminary screening, C934, C971 and C974 grades were selected and further evaluated for flow and viscoelastic properties. It was observed that ethosome-loaded C974 hydrogel at concentration of 0.50 and 0.75% w/w, respectively, demonstrated acceptable plastic flow with distinct yield stress and a frequency independent G′ and G″. Furthermore, the flow and viscoelastic properties were maintained at the 4, 25 and 32 °C. The results from in vitro skin permeation studies indicate that ethosome-loaded C974 hydrogel at 0.5% w/w polymer concentration exhibited similar skin permeation as that of ethosomal formulation.
Conclusion: The results indicate that suitable rheological properties of C974 could facilitate in achieving desired skin permeation of diclofenac while acting as an efficient carrier system for ethosomal vesicles.
This document summarizes a study that investigated the influence of operational parameters on mass transfer resistance in a packed bed bioreactor using Saccharomyces cerevisiae cells immobilized in calcium alginate beads. The parameters varied included flow rate, glucose concentration, and use of chitosan coating. Higher flow rates and glucose concentrations resulted in shorter lag phases and faster glucose consumption times, indicating reduced external mass transfer limitations. Chitosan coating acted as a barrier, resulting in longer lag phases for coated beads compared to uncoated beads. The optimum combination of parameters for maximum ethanol production was a higher flow rate of 30-90 ml/min and glucose concentration of 10-20 g/L.
Similar to Formulation-design-for-optimal-high-shear (20)
2. M. Cavinato et al. / International Journal of Pharmaceutics 387 (2010) 48–55 49
Table 1
Formulation composition for granulation trials with different binder type and amount.
Experiment Diluent type and amount (% w/w) Microcrystalline cellulose
(MCC) amount (% w/w)
Binder type and
amount (% w/w)
Croscarmellose sodium
amount (% w/w)
1 Lactose monohydrate 150 M, 76.0% 20% HPMC, 2.5% 1.5%
2 Lactose monohydrate 150 M, 73.5% 20% HPMC, 5.0% 1.5%
3 Lactose monohydrate 150 M, 71.0% 20% HPMC, 7.5% 1.5%
4 Lactose monohydrate 150 M, 68.5% 20% HPMC, 10.0% 1.5%
5 Lactose monohydrate 150 M, 76.0% 20% PVP, 2.5% 1.5%
6 Lactose monohydrate 150 M, 73.5% 20% PVP, 5.0% 1.5%
7 Lactose monohydrate 150 M, 71.0% 20% PVP, 7.5% 1.5%
8 Lactose monohydrate 150 M, 76.0% 20% PVP, 10% 1.5%
understating of the granulation on-set. In addition, particles have
been often considered inert materials, i.e. interactions between
solid particles and liquid have been rarely contemplated. As an
attempt to correlate physical and chemical interactions between
liquid and solid with the mechanical behaviour of the wet con-
stituents, Palzer (2005) used the concept of glass transition to
describe desired and undesired agglomeration in amorphous pow-
ders.
In this paper the glass transition concept coupled with on-line
impeller torque measurements has been used to give a descrip-
tion of the early stage of the agglomeration process in high-shear
wet granulation process, and particularly the onset of significant
granule growth, here identified as granulation onset. It has been
demonstrated that the granulation onset can be identified as abrupt
increase in torque when the amount of binder liquid added exceeds
a certain threshold indicated here as minimum liquid volume
(MLV).
In particular, a new formulation map has been developed which
combines the key elements of the formulation, namely diluent, dry
binder and liquid binder (note that water which can be viewed also
as granulation process parameter is regarded here only in light of its
properties as binder). From this map the minimum liquid volume
necessary for appreciable granule growth is a function of formula-
tion composition. It is also shown how this formulation map can be
constructed from independent measurements of dry binder glass
transition temperatures using a static humidity conditioning sys-
tem.
2. Materials and methods
Variations of a common active-free pharmaceutical formulation
were chosen as materials for the study due to their standard and
well-known characteristics.
Lactose monohydrate 60 mesh (Capsulac® 60, Molkerei Meg-
gle Wasserburg GmbH & Co. KG, Wasserburg, Germany), lactose
monohydrate 150 mesh (Lactochem® Regular Powder 150 M,
Friesland Foods, Zwolte, The Netherlands), lactose monohy-
drate 200 mesh (Pharmatose® 200 M, DMV-Fonterra Excipients,
Nörten-Hardenberg, Germany), lactose monohydrate 400 mesh
(Sorbolac® 400, Molkerei Meggle Wasserburg GmbH & Co. KG,
Wasserburg, Germany), and microcrystalline cellulose (MCC)
(Pharmacel® 101, DMV International, Veghel, The Netherlands)
were used as diluents. Croscarmellose sodium (Ac-Di-Sol®, FMC
Biopolymer, Philadelphia, USA) was used as disintegrants while
the solid binders were hydroxypropylmethylcellulose (HPMC)
(Pharmacoat® 603/Methocel® E5, Shin-Etsu Chemicals, Niigata,
Japan) and polyvinylpyrrolidone (PVP) (Kollidon® K30, BASF, Lud-
wigshafen, Germany).
Excipients were granulated using deionized water at 20 ◦C.
Experiments were performed in a small scale, top driven gran-
ulator (MiPro, 1900 ml vessel volume, ProCepT, Zelzate, Belgium)
with a stainless steel vessel, a chopper and a three bladed impeller.
Granulator was equipped with a measuring/registering system for
impeller torque and powder temperature values during granu-
lation. Formulation was composed of two diluents (lactose and
cellulose), a solid binder and a disintegrant. The fill level of the ves-
sel was about 40% and the total mass of powder was 400 g for each
experiment. All the experiments have been stopped immediately
after liquid addition so that the massing phase was not performed.
Granulating liquid was added through a tube with a 1 mm diameter
by a computer-controlled dosimeter.
Two sets of experiments have been conducted. First, three
granulation experiments have been carried out to determine the
influence of the impeller speed on the shape of the torque profiles
and the particle size distribution of the final granules at con-
stant formulation. The formulation (on a weight basis) consisted
of approximately: lactose monohydrate 150 M (73.5%), micro-
crystalline cellulose (20%), HPMC (5%) and croscarmellose sodium
(1.5%). The process parameter values were set as follows: the
impeller speed at 500, 850 or 1200 rpm, whereas the total amount
of liquid and liquid addition flow rate have always been fixed at
100 ml and 10 ml/min respectively.
A second set of granulation experiments has been performed
with different formulation compositions under the same pro-
cess conditions (i.e. impeller speed of 850 rpm, chopper speed of
3000 rpm, total amount of water added of 100 ml and water addi-
tion rate of 10 ml/min), in order to determine the influence of
formulation variables on impeller torque profiles and particle size
distribution of granules after liquid addition, for a total of 11 runs.
Changes in formulation composition involved binder type
(HPMC or PVP) and amount (in the range of 2.5–10.0%, w/w) as
detailed in Table 1 and main diluent (i.e. lactose monohydrate) PSD
as indicated in Table 2.
Granule samples were taken immediately after the end of the
wetting time and dried. Drying was performed in two ventilated
phases: a first gentle drying in oven for 10 h with ambient temper-
ature and pressure (20 ◦C and 1 bar), and a second drying in oven
for 1 h with a temperature of 50 ◦C and a pressure of 5 mbar. This
procedure was followed for minimizing incidental alteration in par-
Table 2
Formulation composition for granulation trials with lactose monohydrate having different particle size distribution.
Experiment Diluent type and amount (% w/w) Microcrystalline cellulose
amount (% w/w)
Binder type and
amount (% w/w)
Croscarmellose sodium
amount (% w/w)
9 Lactose monohydrate 60 M, 73.5% 20% HPMC, 5.0% 1.5%
10 Lactose monohydrate 200 M, 73.5% 20% HPMC, 5.0% 1.5%
11 Lactose monohydrate 400 M, 73.5% 20% HPMC, 5.0% 1.5%
3. 50 M. Cavinato et al. / International Journal of Pharmaceutics 387 (2010) 48–55
Fig. 1. Effect of impeller speed on impeller torque profiles. Torque data obtained during the first set of granulation experiments (see Table 1) plotted versus the amount of
liquid added. The formulation is same for all the runs (i.e. 73.5% (w/w) lactose monohydrate 150 M, 20% (w/w) microcrystalline cellulose, 5% (w/w) HPMC and 1.5% (w/w)
croscarmellose sodium).
ticle size distribution due to drying method (e.g. attrition in fluid
bed dryer, caking in oven at high temperature).
Granules particle size distribution was characterized by sieve
analysis. The sieving method consisted on 5 mm of vibration ampli-
tude for a 10 min analysis time. Sieves apertures were: 45, 90, 180,
250, 355, 500, 710, 850 and 1000 m.
Water sorption isotherms at 25 ◦C for HPMC and PVP were
determined using a gravimetric analysis system (IGAsorp, Hiden
Isochema, Warrington, UK). Binder samples were kept at different
relative humidity grades under nitrogen flow; the weight change of
each binder sample during the time course analysis was measured
by a hygrometer. The exposure time of each sample to the different
humidity grade corresponded to the time at which binder sample
weight did not change anymore or otherwise to a maximum of 12 h.
Curves representing influence of water content on binder glass
transition temperature were determined as follows: HPMC and
PVP duplicate samples were kept in a series of 4 hermetic vessels
arranged with saturated salt solutions covering a wide range of rela-
tive humidity (11–95% RH): about 500 mg samples were weighted
and spread through a thin layer (about 0.5 mm). Glass transition
temperature for each sample was measured by temperature mod-
ulated differential scanning calorimetry (TMDSC) (TA Instruments
Q2000, with T0 technology). TMDSC experimental procedure was as
follows: after a first equilibration stage at 80 ◦C and then at −50 ◦C
for 5 min (heating rate respectively 10 ◦C/min and −10 ◦C/min).
Samples were taken to a maximum heating temperature of 120 ◦C
with a 5 ◦C/min heating rate, using a modulation amplitude of ±1 ◦C
every 60 s. Measures were performed using hermetic aluminium
pans (T0 pans), in which 5–10 mg samples were weighted. Water
content in binder samples was measured using the Karl–Fisher
method.
3. Results and discussion
Impeller torque profiles obtained from the first set of experi-
ments (i.e. at constant formulation) are shown in Fig. 1 as a function
of the added liquid, for three different impeller speeds (500, 850 and
1200 rpm). As can be noticed, plotting torque values versus liquid
volume instead of time as typically performed, the shape of the pro-
files obtained with different impeller speed is very similar. It is also
Fig. 2. (a) Effect of impeller speed on the impeller torque profiles of Fig. 1 after numerical filtering and corresponding (b) first derivatives with minimum value determination
(circles).
4. M. Cavinato et al. / International Journal of Pharmaceutics 387 (2010) 48–55 51
Fig. 3. Correlation between torque and granule particle size distribution: (a) impeller torque profile and corresponding first derivative (dashed line) obtained adding 40 ml
of water (up to point A) and 100 ml of water (up to point B) and (b) granule PSD obtained at point A and at point B of (a) and comparison with PSD of dry formulation (dashed
line).
evident that torque increases almost proportionally with increas-
ing the stirring speed. This may suggest identifying a scaling factor
for the impeller speed which, for a given formulation, allows all the
profiles to collapse on a single master curve, greatly reducing the
number of experiments to be run as it has been performed for the
dry phase by Knight et al. (2001).
Focusing on the shape of the profiles in Fig. 1, it can be seen
that initially the torque value increases slightly and linearly with
the amount of liquid, indicating a progressive densification of the
mixture. A decrease of the slope is then observed, in all cases, which
is interpreted as lubrication of the mass, which reduces the strength
of the bulk and consequently the stress on the impeller. When the
volume of the added water is larger than a certain value, an abrupt
increase in torque occurs.
As can be seen in Fig. 1, the torque profiles can be rather noisy.
In order to obtain a precise determination of the torque value cor-
responding to the steep increase in the profile, the torque curves
have been numerically filtered. The resulting profiles are shown in
Fig. 2a. The first derivative was then calculated and also plotted as
a function of the added liquid in Fig. 2b. A minimum in the curves
can be visibly located just before the steep torque increase (marked
by the circles in Fig. 2b). The corresponding liquid volume has been
identified as the minimum liquid volume (MLV) required to yield
substantial agglomeration of the mass for a given operating con-
dition. MLV will be used in the following as a distinctive, clearly
identifiable and reproducible feature of the granulation process.
In the second set of experiments the impeller velocity of 850 rpm
(middle curve in Fig. 2a) has been chosen as reference. To monitor
the evolution of the PSD during the granulation process, this exper-
iment has been run in duplicate; once stopped after the addition
of 40 ml of liquid only (point A in Fig. 3a) and the other after the
addition of the entire amount of water of 100 ml (point B in Fig. 3a).
The granules obtained from both trials have been sampled for
PSD determination. The PSD of these two trials have then been
compared with the PSD of the initial dry formulation in Fig. 3b.
As can be seen in Fig. 3b, the PSD of the granule obtained with
40 ml of liquid (curve A) is almost superimposable to the PSD of the
initial dry formulation (dashed curve in Fig. 3b). On the contrary, a
significant deviation from the dry formulation is observed with the
PSD obtained with 100 ml of added liquid (curve B). This observa-
Fig. 4. Effect of different concentration of HPMC (a) and PVP (b) on MLV determination.
5. 52 M. Cavinato et al. / International Journal of Pharmaceutics 387 (2010) 48–55
Fig. 5. Determination of on-set conditions for granule growth according to the type (HPMC or PVP) and amount of binder and liquid added. The ratio between the amount
of binder and liquid is plotted against the amount of liquid for different binder concentrations. The MLV determined experimentally for PVP and HPMC is also displayed
(squares and circles respectively).
tion indicates that most of the agglomeration process occurs after
40 ml of liquid are added to the system. Remarkably, 40 ml corre-
sponds to the liquid volume required to increase significantly the
torque value (Fig. 2b) and consequently can be considered as the
minimum liquid volume (MLV) required to start most granulation
process. Similar conclusions could be deduced from the experimen-
tal data presented for example by Ritala et al. (1988): dicalcium
phosphate was granulated with different binder solutions observ-
ing an abrupt increase in mean granule diameter when the liquid
saturation exceeds certain specific values.
Having identified the MLV as marker of the granulation onset,
a dedicated experimentation has been designed (as detailed in
Tables 1 and 2) to understand the impact of the formulation com-
ponents on the MLV.
Two common binders (i.e. HPMC and PVP), added as dry powder
in the initial powder mix, in the usual range for pharmaceutical wet
granulation (i.e. from 2.5 to 10%, w/w), have been tested.
Fig. 4 summarizes the results obtained with the two binders at
the various concentrations on the MLV determination. As can be
appreciated, the onset of granulation, measured as MLV, is delayed
(that is a higher amount of liquid is required) with increasing the
binder amount, with both HPMC and PVP. MLV increase resulted
to be greater for HPMC than PVP. In addition, the rate of torque
increase with PVP is higher than that with HPMC (Fig. 4a and b). It
is suggested that this fact is due to a more relevant hygroscopicity
of the PVP powder as compared with HPMC, which determines a
faster formation of a viscous solution.
Plotting the ratio between the amount of binder and liquid
versus the amount of liquid, hyperbolas parametric in the binder
amount are obtained (Fig. 5). Each of these curves describes the
evolution of the granulation process in terms of added liquid for dif-
ferent amount of binder present in the formulation. The minimum
liquid volume determined experimentally for both HPMC and PVP
is also indicated on each curve. As noted above (refer Fig. 4) the
MLV increases with the binder amount for both HPMC and PVP.
Interestingly, as the MLV increases with increasing the binder con-
centration, the ratio binder/liquid does not remain constant, as it
would have been expected the MLV being a simple function of the
solubility of the binder. Since changes in the amount of binder
in the formulation are reflected into the amount of diluent (as
per Table 1), from the results outlined above it can be concluded
that diluent hygroscopicity also plays a role in MLV determina-
tion.
To separate and quantify the effect of diluent and binder on the
onset of granulation, a simplified representation of the relationship
among formulation components in the granulation process is pro-
posed (Fig. 6a). The key players of the process that is liquid binder,
dry binder and diluents (lactose monohydrate and microcrystalline
cellulose) represent the vertex of a ternary diagram.
The dry formulation mix is represented by a point on
binder–diluent axis. With the addition of water, the point in
the diagram representing the actual granulation mix moves from
binder–diluent axis towards the 100% liquid vertex. This ternary
Fig. 6. Formulation map: (a) ternary diagram where each vertex represents the
weight composition of the key components of the granulation mix, namely main
diluent (lactose monohydrate and microcrystalline cellulose), dry binder (HPMC
or PVP) and liquid (water); (b) inset focusing on the most common granulation
area. Circles and squares label MLV experimentally determined for HPMC and PVP
respectively; the points on the diagram for concentrations of binder other than those
tested are interpolated.
6. M. Cavinato et al. / International Journal of Pharmaceutics 387 (2010) 48–55 53
Fig. 7. Moisture sorption isotherms for HPMC (circles) and PVP (squares) at 25 ◦
C.
diagram can be viewed as a granulation map on which the granu-
lation process can be followed (as weight fractions or percentage
of the ternary mixture) given the initial formulation composition.
In practice granulation area is typically limited to high diluent
concentration values as pointed out in Fig. 6b which enlarges the
bottom-left corner of the diagram.
The MLV measured from Table 1 experiments are projected in
the map (symbols in Fig. 6). As can be observed in Fig. 6b the MLV
for HPMC and PVP lie on two straight, non-parallel lines, confirming
the non-obvious influence of the liquid amount on the binder action
already observed from Fig. 5.
Interestingly, the curves constructed by interpolating the MLV
values experimentally obtained for HPMC and PVP intersect the
diluent–liquid axis (corresponding to 0% binder) very closely to
each other (point (A) of Fig. 6). This value represents the water
absorbed by the diluent powders and therefore not accessible for
the binder. On the contrary, the water absorbed by the binder is
indicated by the intersection on binder–liquid axis (i.e. 0% dilu-
ent). In this case, the intersection obtained by interpolating the
experimental MLV values is clearly different for the two binders, as
marked by the points (B) and (C) in Fig. 6, reflecting their different
interaction with the granulating liquid (water).
From this representation, it can be easily concluded that the
onset of granulation for a given formulation is identified by a single,
binder-specific curve. This curve, as shown in the following, can
be constructed from independent measurements on the diluents
(initial moisture) and the binder–liquid mixture.
A physical interpretation for conditions (A), (B) and (C) in Fig. 6,
is also proposed as per the following mechanism:
(1) water drops on the powder bed and penetrates into the diluent
and binder particles;
(2) part of the water is absorbed by the hygroscopic diluents;
(3) the remaining water is absorbed by the binder and acts as plas-
ticizer, decreasing its glass transition temperature, Tg;
(4) when the Tg of the binder–water mixture equals the local tem-
perature, the binder becomes sticky, as indicated by the abrupt
sudden increase in the measured torque, and granule growth
accelerates.
As experimentally verified, the maximum water amounts absorbed
from diluent and binder (steps 3 and 4) in granulation are not
equilibrium values: it is hypothesized that agreement between
the theoretical equilibrium value and the actual absorbed water
amount mainly depends on the different component hygroscopic-
ity and on the mixing energy and efficiency.
In order to determine hygroscopicity of HPMC and PVP, moisture
sorption isotherms (25 ◦C) have been measured by hygrometry.
Results are shown in Fig. 7, where the weight gain of the binder is
reported as a function of the ambient percentage relative humidity
(RH%). As can be noticed, water absorption is extremely non-linear,
dramatically increasing at elevated RH%, especially for PVP which
thus exhibits a much larger hygroscopicity than HPMC.
Glass transition temperature of the moisturized binders, has also
been determined. For this purpose, samples of HPMC and PVP have
been prepared with a certain degree of absorbed water by placing
them in a closed vessel, at different RH%, for 2 weeks, assuming
equilibrium is finally attained after such a long time.
Glass transition temperature of wet binder samples was esti-
mated using Gordon–Taylor (1952) equation:
Tg =
w1Tg1 + kw2Tg2
w1 + kw2
(1)
which is a weighted average of the single component’s Tg’s, cor-
rected by an empirical factor (k) to take into account the water
contribution. Tg1 is the glass transition temperature of the dry
binder and Tg2 that of water (equal to −138 ◦C), while w1 and w2 are
the weight fractions. k values for different water–binder systems
have been calculated e.g. by Hancock and Zografi (1994).
Eq. (1) is used to derive mathematically the amount of water,
w∗
2
, that results in Tg = Ta, where Ta is the operating temperature
(e.g. ambient):
w∗
2 =
Tg1 − Ta
k(Ta − Tg2) + (Tg1 − Ta)
(2)
This water amount is the quantity needed for the binder glass tran-
sition and the formation of a highly viscous mixture. To further
improve the accuracy of the fitting of our experimental data, a more
recent equation to determine Tg (Hancock and Zografi, 1994) has
also been utilized. This equation introduces an additional quadratic
function of composition to the Gordon–Taylor equation, Eq. (1). The
resulting Tg is:
Tg =
w1Tg1 + kw2Tg2
w1 + kw2
+ qw1w2 (3)
where q is an empirical constant reflecting binder–water interac-
tion. Through Eq. (3) it has been calculated the theoretical water
amounts which satisfy the Tg = Ta condition.
7. 54 M. Cavinato et al. / International Journal of Pharmaceutics 387 (2010) 48–55
Fig. 8. Glass transition temperature as a function of the equilibrium water content in samples of HPMC (circles) and PVP (squares); continuous lines are obtained by fitting
experimental data to modified Gordon–Taylor equation, Eq. (3); the dashed line shows ambient temperature as reference.
The curves obtained by fitting the glass transition temperatures
experimentally determined for the different wet samples using Eq.
(3) are illustrated in Fig. 8. The condition Tg = Ta corresponds to
the intersection between the data fitted curves and the ambient
temperature (see Fig. 8).
Note that Eq. (3) fits experimental Tg’s for the system PVP/water
better than for the HPMC/water one. This is due to the fact that the
data fitting for HPMC was performed on a lower number of exper-
imental points at high water weight fraction values. Since HPMC is
less hygroscopic than PVP (see Fig. 7) it was not possible to mois-
turize HPMC samples under static condition with a water weight
fraction higher than 20% at RH% lower than 90%.
The water weight fractions at which the glass transition temper-
ature is equal to that of the ambient (i.e. 0.24 and 0.32 for PVP and
HPMC respectively) are in agreement with water amounts deter-
mined from Fig. 6, that is point (B) and (C) (i.e. 0.21 and 0.36 for
PVP and HPMC respectively).
To sum up, it is remarkable that the onset of the granulation for
a given formulation can be determined from a triangular plot, like
the one presented in Fig. 6, that is constructed from independent
measurements of moisture content of diluents (point A in Fig. 6)
and binder–water ratio (points B and C in Fig. 6) yielding Tg = Ta.
Noteworthy, points B and C in Fig. 6 are derived from measure-
ments of equilibrium data as illustrated in Fig. 8. Discrepancies
between actual and equilibrium data might arise in case the water
absorption kinetics within the granulator bowl is not fast enough
to approach the equilibrium. This could depend on binder hygro-
scopicity, on its competition with diluents in moisture absorption
and on the mixing energy,
The above-mentioned competition for water among diluents
and binder has been investigated further by varying the particle
size distribution (PSD) of the main diluent (i.e. lactose monohy-
drate) while keeping the relative proportion of the formulation
components constant. Lactose monohydrate 60, 150, 200 or 400
mesh has been tested as indicated in Table 2. Resulting torque pro-
files (after filtering) and first derivative are shown in Fig. 9. As can
be appreciated MLV identification is straightforward with coarse
lactose monohydrate (i.e. 60 M and 150 M). On the contrary, it is
hard to identify MLV for the finer lactose monohydrate (200 and
400 mesh).
First derivative for granulation trials performed with lactose
monohydrate 400 mesh is significantly more irregular than that
with coarser lactose, as it can be deduced in Fig. 9b. It is hypothe-
sized that this difference in behaviour is due to sticking of the wet
Fig. 9. Effect of particle size distribution of the main diluent lactose monohydrate on torque profiles: (a) filtered profiles and (b) first derivatives with minimum value
determination (circles).
8. M. Cavinato et al. / International Journal of Pharmaceutics 387 (2010) 48–55 55
powder mix on the granulator wall. The sticking was observed by
the visual inspection of the wet powder through a spy-hole dur-
ing the granulation. First derivative for the mixture with lactose
monohydrate 200 mesh shows a more regular torque increase but
does not show a minimum, as a consequence the MLV could not be
determined. The proposed interpretation is that a different growth
mechanism occurs (e.g. layering growth mechanism). We can con-
clude from this set of experiments that at least for the cases in
which the minimum on the torque first derivative can be identified
there is not much difference between the minimum water amount
required varying the lactose mesh (i.e. 60 and 150 mesh in Fig. 9b).
This may suggest that the MLV is independent of the particle dimen-
sion of the diluent and therefore is a function only of its chemical
nature and hygroscopicity.
4. Conclusions
This work was aimed at developing more systematic and quan-
titative criteria for high-shear wet granulation design on the basis
of the single components physical properties. A novel formulation
map has been proposed which describes the onset of granulation
as a function of the formulation variables (diluent, dry and liquid
binder).
The granulation progress is characterized through impeller
torque measurements and time measurements of granule particle
size distribution. When plotting the torque profiles as a function of
the amount of liquid added an abrupt increase in torque is observed
that is associated to the actual onset of granulation interpreted
as beginning of a significant granule growth (on the basis of the
granule PSD). This abrupt change in torque is quantitatively deter-
mined as minimum in the first derivative of the torque profile with
respect to the added liquid. The amount of liquid at which the
torque derivative is at its minimum is designated here as minimum
liquid volume (MLV).
MLV is greatly dependent on the formulation. It is shown how
to determine MLV as a function of the formulation constituents. A
triangular ‘formulation map’ in which the vertex represent the dilu-
ent, dry and liquid binder is constructed. It is demonstrated how
the points on the edges of the triangle can be determined by inde-
pendent measurement of the diluents hygroscopic capacity and
the glass transition of the binder–water system. The granulation
onset values for the different formulations can be then extrapo-
lated from this diagram. Note that the actual kinetics of the physical
processes within the granulator may lead to slight departures from
the predictions based on equilibrium data. Notwithstanding these
discrepancies, we believe that the method outlined in this paper
has a huge potential to increase the predictability of different for-
mulations on the basis of the physical properties of the single
component.
References
Betz, G., Bürgin, P.J., Leuenberger, H., 2004. Power consumption measurement and
temperature recording during granulation. Int. J. Pharm. 272, 137–149.
Briens, L., Daniher, D., Tallevi, A., 2007. Monitoring high-shear granulation using
sound and vibration measurements. Int. J. Pharm. 331, 54–60.
Daniher, D., Briens, L., Tallevi, A., 2008. End-point detection in high-shear granulation
using sound and vibration signal analysis. Powder Technol. 181, 130–136.
Ennis, B.J., 2006. Theory of granulation: an engineering perspective. In: Parikh, D.M.
(Ed.), Handbook of Pharmaceutical Granulation Technology, 2nd ed. Taylor and
Francis Group, New York (U.S.A.).
Faure, A., York, P., Rowe, R.C., 2001. Process control and scale-up of pharmaceutical
wet granulation processes: a review. Eur. J. Pharm. Biopharm. 52, 269–277.
Gokhale, R., Sun, Y., Shukla, A.J., 2006. High-shear granulation. In: Parikh, D.M. (Ed.),
Handbook of Pharmaceutical Granulation Technology, 2nd ed. Taylor and Francis
Group, New York (U.S.A.).
Hancock, B.C., Zografi, G., 1994. The relationship between the glass transition tem-
perature and the water content of amorphous pharmaceutical solids. Pharm.
Res. 11.
Holm, P., 1997. High shear mixer granulators. In: Parikh, D.M. (Ed.), Handbook of
Pharmaceutical Granulation Technology, 1st ed. Taylor and Francis Group, New
York (U.S.A.).
Knight, P.C., Seville, J.P.K., Wellm, A.B., Instone, T., 2001. Prediction of impeller torque
in high shear powder mixers. Chem. Eng. Sci. 56, 4457–4471.
Landin, M., Rowe, R.C., York, P., 1995. Characterization of wet powder masses with a
mixer torque rheometer. 3. Nonlinear effects of shaft speed and sample weight.
J. Pharm. Sci. 84 (5), 557–560.
Landin, M., York, P., Cliff, M.J., Rowe, R.C., Wigmore, A.J., 1996. The effect of batch size
on scale-up of pharmaceutical granulation in a fixed bowl mixer-granulator. Int.
J. Pharm. 134, 243–246.
Leuenberger, H., 1982. Granulation, new techniques. Pharm. Acta Helv. 57, 72–
82.
Leuenberger, H., Puchkov, M., Krausbauer, E., Betz, G., 2009. Manufacturing pharma-
ceutical granules: Is the granulation end-point a myth? Powder Technol. 189,
141–148.
Litster, J.D., Ennis, B.J., 1999. Size reduction and size enlargement. In: Perry, R.H.,
Green, D.W. (Eds.), Perry’s Chemical Engineers’ Handbook. McGraw-Hill Com-
panies, New York (U.S.A.).
Mort, P.R., 2005. Scale-up of binder agglomeration processes. Powder Technol. 150,
86–103.
Palzer, P., 2005. The effect of glass transition on the desired and undesired agglom-
eration of amorphous food powders. Chem. Eng. Sci. 60, 3959–3968.
Ritala, M., Holm, P., Schaefer, T., Kristensen, H.G., 1988. Influence of liquid bonding
strength on power consumption during granulation in a high shear mixer. Drug
Dev. Ind. Pharm. 14, 1041–1060.
Tardos, G.I., Kahn, M., Mort, P., 1997. Critical parameters and limiting conditions in
binder granulation of fine powders. Powder Technol. 94, 245–258.
Tardos, G.I., Hapgood, K.P., Ipadeola, O.O., Michaels, J.N., 2004. Stress measurements
in high shear granulators using calibrated ‘test’ particles: application to scale-up.
Powder Technol. 140, 217–227.
Tardos, G.I., 2005. Wet-granulation research with application to scale-up. China
Particuology 3, 191–195.
Wildeboer, W.J., Litster, J.D., Cameron, I.T., 2005. Modelling nucleation in wet gran-
ulation. Chem. Eng. Sci. 60, 3751–3761.